vimarsana.com
Home
Live Updates
Stefan Quenneville - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Stefan quenneville - Page 1 : vimarsana.com
NLH has 173% upside, Echelon says
Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his “Buy” rating on Nova Leap Health.
Massachusetts
United-states
Chris-dobbin
Stefan-quenneville
Nova-leap-health-stock
Unitedhealth-group-inc
Amedisys
Echelon-capital-markets
Nova-leap-health
Nova-leap-health-stock-quote
Nova-leap
Unitedhealth-group
NSCI stock is undervalued, Echelon says
Following the release of preliminary fourth quarter results, Echelon analyst Stefan Quenneville remains bullish about Nanalysis Scientific.
Stefan-quenneville
Sean-krakiwsky
Nanalysis-scientific
Nanalysis-scientific-stock-quote
VPH stock has price target lowered at Echelon
Following the company’s fourth quarter results, Echelon Capital Markets analyst Stefan Quenneville has lowered his price target on Valeo Pharma
Valeo-pharma
Stefan-quenneville
Steve-saviuk
Echelon-capital-markets
Valeo-pharma-stock-quote
Tuesday's analyst upgrades and downgrades - The Globe and Mail
Inside the Market’s roundup of some of today’s key analyst actions
Winnipeg
Manitoba
Canada
Serbia
Texas
United-states
Couche
Poitou-charentes
France
Nevada
Quebec
Cobre
Buy ATE stock for a double, Echelon says
Following the company’s Q2, 2024 interim results, Echelon analyst Stefan Quenneville still thinks there is money to be made on Antibe Therapeutics
Dan-legault
Stefan-quenneville
Echelon-capital-markets
Antibe-therapeutics
Antibe-therapeutics-stock-quote
Speculative-buy
vimarsana © 2020. All Rights Reserved.